lynparza

Lynparza tablets approved for NHS use in platinum-sensitive, BRCA-mutated ovarian, fallopian tube or peritoneal cancer

January 16, 2020
Sales and Marketing AstraZeneca, MSD, NHS, NICE, UK, lynparza

It has been announced that tablet form of Lynparza (olaparib), the PARP inhibitor developed by AstraZeneca and MSD, has secured …

49391632522_2133e0262f_b

US-China trade deal sees changes on drug patents

January 16, 2020
Business Services China, Chinese Drug Patents, Trade Deal, US Drug Patents, US-China Trade Deal

The US and China signed the first part of a broader trade pact that included setting up a system to …

abbvie_0

AbbVie’s Skyrizi outpaces Novartis’ Cosentyx in plaque psoriasis skin clearance

January 16, 2020
Research and Development AbbVie, Cosentyx, Novartis, Skyrizi, pharma, psoriasis

AbbVie has made it known that Skyrizi (risankizumab) outpaced Novartis’ Cosentyx (secukinumab) at Phase 3 in the treatment of plaque …

HIV infections fall by 73% in bi and gay British men

January 16, 2020
Business Services AIDS, AIDS Epidemic, HIV, NHS, NHS England, PrEP, nhs scotland

Public Health England has released figures that show that HIV rates in bi and gay men have fallen by 73% …

NICE shoots down Keytruda in head and neck cancer over data concerns

January 16, 2020
Sales and Marketing Cancer, NHS, NICE, UK, keytruda, pharma

It has been revealed that NICE has chosen to reject MSD’s blockbuster immunotherapy Keytruda (pembrolizumab) for routine use on the …

dw-anzcxqaqavhl

FDA approves Lannett’s cocaine-based nasal spray

January 15, 2020
Research and Development FDA, Lannett, Numbrino, cocaine

It has been announced that the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for “the …

40542895134_9f6048fa40_b

FDA panel votes against Nektar opioid painkiller

January 15, 2020
Research and Development Bernie Opioids, Big Pharma, Trump opioids, opioid, opioid crisis, opioids, pharma

FDA unanimously voted against Nektar Therapeutics opioid pankiller (NKTR-181) for chronic lower back pain, prompting the company to withdraw its …

Pfizer’s Ibrance combo authorised via the Cancer Drugs Fund for advanced breast cancer

January 15, 2020
Research and Development Cancer Drugs Fund, NICE, Pfizer, ibrance, pharma

NICE, the drug watchdog for England and Wales, has given its approval for Pfizer’s Ibrance (palbociclib) in combination with AstraZeneca’s …

131224-f-im476-001

Rochester Drug Cooperative ceases opioid sales following criminal charges

January 15, 2020
Research and Development Bernie Sanders, Trump opioids, opioid, opioid crisis, opioids

The Rochester Drug Cooperative (RDC) has announced it will no longer distribute opioid medications after two of its executives were …

48721589102_164e25393b_b

Democrat Presidential Candidates pledge to lower drug prices without Congress’ help

January 15, 2020
Research and Development Bernie Sanders, GOP, Trump, US President, US Presidential Election, democrats, republican

Two Democratic presidential candidates said that if they are elected president they will act immediately to reduce the cost of …

6934974672_fd18b2ea20_b

Chinese coronavirus found in Thailand

January 14, 2020
Manufacturing and Production China, WHO, World Health Organisation, Wuhan, pneumonia, thailand

The recent viral pneumonia outbreak in Wuhan China has spread to Thailand.The patient is a 61 year old woman who …

shutterstock_512649

MorphoSys and Incyte forge potential $1.1bn partnership to develop B cell malignancy drug candidate

January 14, 2020
Manufacturing and Production, Sales and Marketing Incyte, morphosys, pharma, tafasitamab

MorphoSys and Incyte have joined together in a partnership to develop and commercialise the latter’s anti-CD19 antibody tafasitamab as a …

business-laptop-computer-money

Acasti’s shares plunge as new drug does not meet primary endpoint

January 14, 2020
Manufacturing and Production Acasti, Acasti Pharma, CaPre, Primary Endpoint, Shares

Acasti Pharma’s shares plunged by as much as 67% this week as its drug CaPre failed to meet its primary …

biogen_austria_238

Biogen picks up Pfizer’s Phase 1 therapy for Alzheimer’s symptoms in potential $700m deal

January 14, 2020
Manufacturing and Production, Sales and Marketing Alzheimer's, Biogen, Pfizer, pharma

Biogen has entered into an agreement with Pfizer to acquire the latter’s Phase 1 candidate PF-05251749 in order to develop …

nhs_old_hospital_1

NHS to pioneer Novartis injection that reduces cholesterol

January 14, 2020
Manufacturing and Production NHS, NHS England, bad cholesterol, cholesterol, heart attack

The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces bad cholesterol.It has reached a deal with …

zytiga_outside

NHS Scotland recommends Janssen’s Zytiga combo for newly diagnosed prostate cancer

January 13, 2020
Sales and Marketing Cancer, NHS, Scotland, nhs scotland, prostate cancer

Janssen’s Zytiga (abiraterone acetate) has just been approved by the Scottish Medicines Consortium (SMC), meaning that male patients on the …

jp-kress_mor

Working Life Interview: Jean-Paul Kress, CEO of MorphoSys

January 13, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Working Life, feature, morphosys, pharma

With a medical doctorate as well as degrees in pharmacology and immunology under your belt, was your path always to …

FDA approves Astellas injectable antifungal drug for newborns

January 13, 2020
Sales and Marketing Astellas, Atellas Pharma, FDA, fungal virsus

The FDA has approved the first antifungal drug to specifically treat invasive candidiasis in newborns. From Astellas, the new drug …

shutterstock_273326141

Eli Lilly to boost immunology portfolio with $1.1bn Dermira acquisition

January 13, 2020
Sales and Marketing Dermira, Eli Lilly, pharma

Eli Lilly has announced it has entered into an agreement to acquire Dermira, a biopharmaceutical firm focused on the development …

flag-1267780_1280

Pakistan registers cases against 200 pharmaceutical companies

January 13, 2020
Sales and Marketing National Task Force, Pakistan, Pakistani Pharmaceuticals, corruption

The Punjab Quality Control Board has sent at least 74 cases to the drugs courts for prosecution, and has overall …

The Gateway to Local Adoption Series

Latest content